Trading Window

Date: 28th September, 2026 To, To, The Manager, The Manager, Department of Corporate Services, Listing Department, BSE Limited National Stock Exchange of India Ltd. P. J. Towers, Dalal Street, ‘Exchange Plaza’, Bandra Kurla Complex, Fort, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Scrip Code:533573 NSE Symbol: APLLTD Dear Sir / Madam, Sub.: Intimation of closure of trading window This is to inform the exchanges that pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 read with the Code of Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons and their Immediate Relatives of the Company and Circulars of BSE Limited (No. LIST/COMP/01/2019-20) and National Stock Exchange of India Limited (No. NSE/CML/2019/11), both dated 2nd April, 2019, the trading window for dealing in securities of the Company will remain closed from 1st October, 2026 till 48 hours after the declaration of the Unaudited Financial Results of the Company, for the quarter and half year ending on 30th September, 2026. We request you to kindly take the same on record. Thanking you, Yours faithfully, For Alembic Pharmaceuticals Limited Chirag K. Shukla Company Secretary ALEMBIC PHARMACEUTICALS LIMITED REGD. OFFICE: ALEMBIC ROAD, VADODARA - 390 003. ● TEL: (0265) 2280550, 2280880 ● FAX: (0265) 2281229 Website : www.alembicpharmaceuticals.com ● E-mail : alembic@alembic.co.in ● CIN : L24230GJ2010PLC061123